Comparison of two once-daily regimen Consisting of nelfinavir, didanosine and stavudine in antiretroviral therapy-naïve adults: 48-week results from the antiretroviral evaluation study (ARES)

Lowe, S.H.; Wensing, A.M.J.; Hassink, E.A.; ten Kate, R.W.; Richer, C.; Schreij, G.; Koopmans, P.P.; Juttmann, J.R.; van der Tweel, I.; Lange, J.M.A.; Borleffs, J.C.C.

Comparison of two once-daily regimen Consisting of nelfinavir, didanosine and stavudine in antiretroviral therapy-naïve adults: 48-week results from the antiretroviral evaluation study (ARES)

DSpace/Manakin Repository

Comparison of two once-daily regimen Consisting of nelfinavir, didanosine and stavudine in antiretroviral therapy-naïve adults: 48-week results from the antiretroviral evaluation study (ARES)

Lowe, S.H.; Wensing, A.M.J.; Hassink, E.A.; ten Kate, R.W.; Richer, C.; Schreij, G.; Koopmans, P.P.; Juttmann, J.R.; van der Tweel, I.; Lange, J.M.A.; Borleffs, J.C.C.

(2005) HIV Clinical Trials, volume 6, issue 5, pp. 235 - 245

(Article)

Download/Full Text

Open Access version via Utrecht University Repository

Unknown

Keywords: International (English)

ISSN: 1528-4336

Publisher: Thomas Land Publishers Inc.

(Peer reviewed)

See more statistics about this item